A Research Study for Patients With Prostate Cancer
NCT00106418
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
35
Enrollment
INDUSTRY
Sponsor class
Conditions
Prostate Cancer
Metastases
Interventions
DRUG:
Romidepsin
Sponsor
Celgene